POINT Biopharma Global Inc., (PNT) Social Stream
POINT BIOPHARMA GLOBAL INC (PNT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PNT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-16 | 3 | $17 | $8 | $12.5 | $14.02 | -10.84% |
| 2021-12-06 | 4 | $23 | $8 | $16 | $14.02 | 14.12% |
| 2022-05-13 | 5 | $65 | $7 | $27.25 | $14.02 | 94.37% |
| 2022-05-31 | 5 | $65 | $14 | $30.5 | $14.02 | 117.55% |
| 2022-08-12 | 6 | $65 | $14 | $30.5 | $14.02 | 117.55% |
| 2022-08-15 | 7 | $65 | $14 | $30.5 | $14.02 | 117.55% |
| 2022-08-16 | 7 | $65 | $14 | $28.4 | $14.02 | 102.57% |
| 2022-09-14 | 9 | $65 | $19 | $28.166 | $14.02 | 100.9% |
| 2022-09-16 | 9 | $65 | $19 | $27.285 | $14.02 | 94.61% |
| 2022-09-18 | 9 | $65 | $17 | $27 | $14.02 | 92.58% |
| 2022-09-19 | 9 | $65 | $17 | $27.428 | $14.02 | 95.63% |
| 2022-11-09 | 10 | $65 | $17 | $26.5 | $14.02 | 89.02% |
| 2022-11-15 | 10 | $65 | $14 | $25 | $14.02 | 78.32% |
| 2022-11-16 | 10 | $65 | $12 | $23.375 | $14.02 | 66.73% |
| 2022-11-21 | 10 | $65 | $12 | $23.75 | $14.02 | 69.4% |
| 2022-11-30 | 11 | $65 | $12 | $22.666 | $14.02 | 61.67% |
| 2022-12-14 | 12 | $65 | $10 | $21.4 | $14.02 | 52.64% |
| 2023-02-01 | 11 | $28 | $10 | $16.555 | $14.02 | 18.08% |
| 2023-02-24 | 11 | $28 | $10 | $16.444 | $14.02 | 17.29% |
| 2023-03-27 | 11 | $28 | $11 | $16.555 | $14.02 | 18.08% |
| 2023-05-18 | 11 | $28 | $11 | $16.333 | $14.02 | 16.5% |
| 2023-06-20 | 11 | $28 | $12 | $16.555 | $14.02 | 18.08% |
| 2023-06-21 | 11 | $28 | $12 | $16.777 | $14.02 | 19.66% |
| 2023-08-14 | 11 | $28 | $13 | $17 | $14.02 | 21.26% |
| 2023-08-28 | 10 | $27 | $13 | $16.888 | $14.02 | 20.46% |
| 2023-09-25 | 11 | $27 | $11 | $16.5 | $14.02 | 17.69% |
| 2023-10-03 | 10 | $27 | $11 | $16.062 | $14.02 | 14.56% |
| 2023-10-04 | 10 | $27 | $11 | $16.214 | $14.02 | 15.65% |
| 2023-10-06 | 10 | $27 | $12.5 | $16.357 | $14.02 | 16.67% |
| 2023-11-13 | 10 | $27 | $12.5 | $16.357 | $14.02 | 16.67% |
The Trend in the Analyst Price Target
PNT's average price target has moved down $0.2 over the prior 146 days.
PNT reports an average of 91.49% for its upside potential over the past 41 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-06 | 11 | 28 | 11.0 | 16.555 | 7.85 | 110.89% |
| 2023-05-18 | 11 | 28 | 11.0 | 16.333 | 10.45 | 56.3% |
| 2023-06-01 | 11 | 28 | 12.0 | 16.555 | 9.12 | 81.52% |
| 2023-08-16 | 10 | 27 | 13.0 | 16.888 | 7.71 | 119.04% |
| 2023-11-13 | 10 | 27 | 12.5 | 16.357 | 13.37 | 22.34% |
PNT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.4 | 3 | 0 | 7 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 52 weeks, PNT's average broker recommendation rating worsened by 1.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how POINT BIOPHARMA GLOBAL INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -3282.73% of that group.
- POINT BIOPHARMA GLOBAL INC's number of analysts covering the stock is greater than 3182.18% of stocks in the small market cap category.
- In the context of Pharmaceutical Products stocks, POINT BIOPHARMA GLOBAL INC's upside potential (average analyst target price relative to current price) is greater than 1036.45% of them.
- In the context of Healthcare stocks, POINT BIOPHARMA GLOBAL INC's average analyst price target is higher than 1311.46% of them.
In the Pharmaceutical Products industry, IVA, ANNX, and NRIX are the three stocks most similar to POINT BIOPHARMA GLOBAL INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for PNT? Use POWR Ratings for clearer insight into price direction.